Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
2.750
+0.060 (2.23%)
At close: Sep 5, 2025, 4:00 PM
2.760
+0.010 (0.36%)
After-hours: Sep 5, 2025, 7:53 PM EDT
Clover Health Investments Revenue
Clover Health Investments had revenue of $477.62M in the quarter ending June 30, 2025, with 34.07% growth. This brings the company's revenue in the last twelve months to $1.61B, up 22.12% year-over-year. In the year 2024, Clover Health Investments had annual revenue of $1.37B with 8.52% growth.
Revenue (ttm)
$1.61B
Revenue Growth
+22.12%
P/S Ratio
0.86
Revenue / Employee
$2,820,877
Employees
570
Market Cap
1.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.37B | 107.61M | 8.52% |
Dec 31, 2023 | 1.26B | 63.77M | 5.32% |
Dec 31, 2022 | 1.20B | -162.08M | -11.91% |
Dec 31, 2021 | 1.36B | 671.35M | 97.30% |
Dec 31, 2020 | 690.02M | 235.27M | 51.74% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CLOV News
- 3 days ago - Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way - GlobeNewsWire
- 26 days ago - Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential - Seeking Alpha
- 4 weeks ago - Clover Health Investments, Corp. (CLOV) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth - GlobeNewsWire
- 4 weeks ago - Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease - GlobeNewsWire
- 5 weeks ago - Clover Health Applauds White House and CMS' Push to “Tear Down Digital Walls,” Accelerating and Simplifying Access to Health Data for Patients and Their Clinicians - GlobeNewsWire
- 5 weeks ago - Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution - GlobeNewsWire
- 6 weeks ago - Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire